Verastem, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
VSTM Company Description
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
VSTM Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VSTM Smart Score
Score Breakdown
VSTM Company Description
Show More
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of VSTM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by VSTM's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on VSTM's company Twitter account
WallStreetBets
Number of mentions of VSTM in WallStreetBets Daily Discussion
VSTM News
Recent insights relating to VSTM
CNBC Recommendations
Recent picks made for VSTM stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VSTM
Corporate Flights
Flights by private jets registered to VSTM
Our Analysis